ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 98 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $76,000 | +38.2% | 10,250 | -53.6% | 0.00% | -20.0% |
| Q1 2020 | $55,000 | -62.3% | 22,100 | -12.0% | 0.01% | -58.3% |
| Q4 2019 | $146,000 | +22.7% | 25,100 | +11.8% | 0.01% | 0.0% |
| Q3 2019 | $119,000 | -25.6% | 22,450 | -15.3% | 0.01% | -33.3% |
| Q2 2019 | $160,000 | -34.4% | 26,506 | -1.9% | 0.02% | -40.0% |
| Q1 2019 | $244,000 | +83.5% | 27,006 | +69.4% | 0.03% | +57.9% |
| Q4 2018 | $133,000 | -31.1% | 15,940 | +14.3% | 0.02% | -17.4% |
| Q3 2018 | $193,000 | – | 13,940 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |